SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
OncoMed Pharmaceuticals, Inc. Announces Presentations of Anti-Notch2/3 and Demcizumab Clinical Data at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Meeting